Loading stock data…
DHR
$175.15-3.80 (-2.12%)
Market ClosedLast close May 1
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Danaher Corporation in the Healthcare sector is trading at $175.15. The stock is currently near its 52-week low of $174.60, remaining 15.8% below its 200-day moving average. Technical signals show oversold RSI of 22 and bearish MACD signal, explaining why DHR maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 22) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$175.15
Potential Downside
45.9%
Whystock Fair Value$94.77
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus22 analysts
Mean target$250.14+42.8%
Range$205.00 – $310.00
Fundamentals
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$130.26B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
35.67
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Strong income play. Yield provides a meaningful total return floor.
82.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.50%
Volume
Today's trading volume
3.88M
Recent News
Is Corning Stock A Buy At 50 Times Earnings?
Corning (GLW) reported Q1 2026 core sales of $4.35 billion, representing an 18% year-over-year increase. The core insight hiding beneath this headline beat is how entirely the AI-driven acceleration is offsetting the more modest growth currently seen in the company's traditional Glass Innovations segment.
Danaher Euro Debt Raise Reshapes Masimo Deal And Valuation Story
Danaher (NYSE:DHR) has announced a multi billion euro senior notes offering to fund its planned acquisition of Masimo Corporation. The euro denominated debt issuance is intended to cover the purchase of Masimo and may also support other corporate priorities. The move signals a major capital allocation decision and a planned expansion of Danaher's medical technology footprint. For investors watching NYSE:DHR, this financing decision comes as the share price stands at $178.8 and longer term...
Stanley Black's Q1 Earnings Beat Estimates, Revenues Rise Y/Y
SWK beats Q1 estimates and lifts 2026 outlook, but faces organic sales pressure and margin declines despite segment growth.
Ingersoll Rand's Q1 Earnings & Revenues Top Estimates, Up Y/Y
IR beats Q1 estimates on revenues and earnings, but organic sales and orders slip while margins contract despite segment growth.
Top Research Reports for Lam Research, BlackRock & Corning
Lam Research leads top research picks as AI-driven chip demand fuels strong gains, while BlackRock and Corning ride growth in AUM and optical solutions.